CM
Conor McNamara RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
5.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $73 |
23%
upside
| 3 | -8.4% |
0
%
| 3 Sep ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $5 |
47%
upside
| 1 | +52% |
0
%
| 12 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $255 |
22%
upside
| 1 | +40% |
0
%
| 8 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $3 |
83%
upside
| 2 | -12% |
0
%
| 7 Aug ‘25 8 months ago |
|
|
|
Sector Perform
Maintained
| $46 |
56%
downside
| 1 | – |
–
| 7 Aug ‘25 8 months ago |
|
|
|
Outperform
Upgraded
| $87 |
14%
upside
| 3 | +11% |
0
%
| 6 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $17 |
100%
upside
| 2 | -22% |
0
%
| 4 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $126 |
6%
downside
| 2 | +28% |
0
%
| 1 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $409 |
37%
upside
| 2 | +4.4% |
0
%
| 1 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $204 |
55%
upside
| 2 | -9.2% |
0
%
| 30 Jul ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $637 |
21%
upside
| 1 | +9.2% |
0
%
| 24 Apr ‘25 1 year ago |
|
|
|
Outperform
Reiterated
| $250 |
28%
upside
| 1 | -0.63% |
0
%
| 23 Apr ‘25 1 year ago |
|